Loading ...

Stock Quote tgr

tgr Stock Price Today

tgr Price History

tgr Stock Price History

tgr History

Last Price tgr

Close Price tgr

Day Change tgr

After Hours Quote tgr

Open Price tgr

Day Range tgr

Year Range tgr

Projected Yield tgr

Market Cap tgr

Stock Volume tgr

Average Volume tgr

Forward Price tgr

PE for tgr

PB for tgr

PS for tgr

PCF for tgr

price earnings ratio tgr

price to book ratio tgr

price to sales ratio tgr

price to cash flow ratio tgr

Stock Quote Tassal Group Ltd

Tassal Group Ltd Stock Price today

Tassal Group Ltd Price history

Tassal Group Ltd Stock Price history

Tassal Group Ltd history

Last Price Tassal Group Ltd

Close Price Tassal Group Ltd

Day Change Tassal Group Ltd

After Hours Quote for Tassal Group Ltd

Open Price Tassal Group Ltd

Day Range Tassal Group Ltd

Year Range Tassal Group Ltd

Projected Yield Tassal Group Ltd

Market Cap Tassal Group Ltd

Stock Volume Tassal Group Ltd

Average Volume Tassal Group Ltd

Forward Price Tassal Group Ltd

pe Tassal Group Ltd

pb Tassal Group Ltd

ps Tassal Group Ltd

pcf Tassal Group Ltd

price earnings ratio Tassal Group Ltd

price to book ratio Tassal Group Ltd

price to sales ratio Tassal Group Ltd

price to cash flow ratio Tassal Group Ltd

What Does This Company Do?
Tassal Group Ltd is the provider of Atlantic salmon in Australia. Its operations include hatching, farming, processing, sales and marketing of Atlantic salmon.
Sector
Consumer Defensive
Industry
Confectioners
Stock Type
Employees
474
Stock Style
Small Core

Key Stats  TGR More...

Key Stats TGR

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .

News  tgr - Tassal Group Ltd More...

Interim Data From Phase 1 Dose Escalation Clinical Trial of TGR-1202, the Once-Daily PI3K Delta Inhibitor, Demonstrates Significant Clinical Activity and Lack of Hepatic Toxicity in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma
Preliminary Data From Ongoing Phase I/II Dose Escalation Study of TG-1101 (Ublituximab) in Combination With TGR-1202 in Heavily Pre-treated Relapsed/Refractory B-Cell Malignancies Demonstrates Encouraging Clinical Activity and Safety
TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 56th American Society of Hematology Annual Meeting
TG Therapeutics Announces Exercise of License Option for Its Novel, Next Generation PI3K-Delta Inhibitor, TGR-1202
TG Therapeutics Announces Collaboration for a Clinical Trial of TGR-1202 in Combination With Ibrutinib (Imbruvica(R)) for Patients With Select B-Cell Malignancies
TG Therapeutics, Inc. Announces Third Quarter 2014 Financial Results and Business Update
TG Therapeutics Announces Special Protocol Assessment (SPA) Agreement With the FDA for Its First Phase 3 Clinical Trial of TG-1101 (ublituximab) in Combination With Imbruvica(R) (ibrutinib) for Patients With Previously Treated Chronic Lymphocytic Leukemia
Data From Phase 2 Clinical Trial of TG-1101 (Ublituximab) and Ibrutinib Shows Compelling Clinical Activity in Patients With Previously Treated, High-Risk Chronic Lymphocytic Leukemia (CLL)
UPDATE -- TG Therapeutics, Inc. to Present at the 16th Annual Rodman & Renshaw Global Investment Conference
TG Therapeutics, Inc. to Present at the 16th Annual Rodman & Renshaw Global Investment Conference
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days

Analysis  tgr - Tassal Group Ltd More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!

More reports tgr - Tassal Group LtdMore...

Click above to view more mutual fund data and stats for tgr - Tassal Group Ltd.

  • Performance
  • Asset Allocation
  • Dividend and Capital Gains Distribution
  • News, Alerts and Opinions
  • Video reports
  • Management
  • Filings

Ownership   TGR More ...

Ownership TGR

DFA International Small Cap Value I
Vanguard Total Intl Stock Index Inv
iShares MSCI EAFE Small-Cap
DFA International Small Company I
CREF Stock
Stock Price Quote: tgr Tassal Group Ltd - XASX - Morningstar
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry

Previous: tmm - Tasmania Mines Ltd  |  Next: 519091 - Tasty Bite Eatables Ltd